Cargando…
Cardiomyocyte glucagon receptor signaling modulates outcomes in mice with experimental myocardial infarction
OBJECTIVE: Glucagon is a hormone with metabolic actions that maintains normoglycemia during the fasting state. Strategies enabling either inhibition or activation of glucagon receptor (Gcgr) signaling are being explored for the treatment of diabetes or obesity. However, the cardiovascular consequenc...
Autores principales: | Ali, Safina, Ussher, John R., Baggio, Laurie L., Kabir, M. Golam, Charron, Maureen J., Ilkayeva, Olga, Newgard, Christopher B., Drucker, Daniel J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4314543/ https://www.ncbi.nlm.nih.gov/pubmed/25685700 http://dx.doi.org/10.1016/j.molmet.2014.11.005 |
Ejemplares similares
-
Inactivation of the cardiomyocyte glucagon-like peptide-1 receptor (GLP-1R) unmasks cardiomyocyte-independent GLP-1R-mediated cardioprotection()()
por: Ussher, John R., et al.
Publicado: (2014) -
Glucagon-Like Peptide-1 Receptor Activation Modulates Pancreatitis-Associated Gene Expression But Does Not Modify the Susceptibility to Experimental Pancreatitis in Mice
por: Koehler, Jacqueline A., et al.
Publicado: (2009) -
Glucagon-like Peptide-1 receptor Tie2+ cells are essential for the cardioprotective actions of liraglutide in mice with experimental myocardial infarction
por: McLean, Brent A., et al.
Publicado: (2022) -
Glucagon-like peptide-1 receptor co-agonists for treating metabolic disease
por: Baggio, Laurie L., et al.
Publicado: (2020) -
Oxyntomodulin increases intrinsic heart rate through the glucagon receptor
por: Mukharji, Auyon, et al.
Publicado: (2013)